Not appropriate for those with B12 hypersensitivity
BPC-157 was removed from the FDA Category 2 list in April 2026 and is under formal compounding review
The first is single-site tendon or ligament injury: patellar tendinopathy, Achilles tendinopathy, plantar fasciitis, rotator cuff partial tears
Remember, the original BPC-157 research was looking at the gut
It is studied in preclinical models to investigate NNMTs role in metabolic regulation, NAD+ metabolism modulation, mitochondrial function effects, and potential metabolic benefits
This process is driven by the upregulation of Vascular Endothelial Growth Factor (VEGF), which facilitates increased delivery of blood and, consequently, growth factors crucial for tissue repair 1 2